• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endo-bariatric therapies as a treatment strategy for MASLD.

作者信息

Gudur Anuragh, Laird Hannah, Shah Neeral, Podboy Alexander

机构信息

Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Department of Medicine, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia, USA.

出版信息

Clin Liver Dis (Hoboken). 2024 Apr 4;23(1):e0126. doi: 10.1097/CLD.0000000000000126. eCollection 2024 Jan-Jun.

DOI:10.1097/CLD.0000000000000126
PMID:38576471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10994489/
Abstract
摘要

相似文献

1
Endo-bariatric therapies as a treatment strategy for MASLD.内镜减重治疗作为非酒精性脂肪性肝病的一种治疗策略。
Clin Liver Dis (Hoboken). 2024 Apr 4;23(1):e0126. doi: 10.1097/CLD.0000000000000126. eCollection 2024 Jan-Jun.
2
Emerging therapies for MASLD and their impact on plasma lipids.非酒精性脂肪性肝炎的新兴疗法及其对血脂的影响。
Am J Prev Cardiol. 2024 Feb 5;17:100638. doi: 10.1016/j.ajpc.2024.100638. eCollection 2024 Mar.
3
Oxidative stress in metabolic dysfunction-associated steatotic liver disease (MASLD): How does the animal model resemble human disease?代谢相关脂肪性肝病（MASLD）中氧化应激：动物模型与人疾病的相似之处有哪些？
FASEB J. 2024 Feb 15;38(3):e23466. doi: 10.1096/fj.202302447R.
4
MASLD treatment-a shift in the paradigm is imminent.非酒精性脂肪性肝病治疗——范式转变即将来临。
Front Med (Lausanne). 2023 Dec 11;10:1316284. doi: 10.3389/fmed.2023.1316284. eCollection 2023.
5
Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.经活检证实的脂肪性肝病和脂肪性肝炎患者的循环激素：一项多中心观察性研究。
Metabolism. 2023 Nov;148:155694. doi: 10.1016/j.metabol.2023.155694. Epub 2023 Sep 25.
6
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.代谢功能障碍相关性脂肪性肝病及其病理生理学、与动脉粥样硬化和心血管疾病的关联，以及治疗方法。
Int J Mol Sci. 2023 Oct 23;24(20):15473. doi: 10.3390/ijms242015473.
7
Endoplasmic reticulum stress inhibitor may substitute for sleeve gastrectomy to alleviate metabolic dysfunction-associated steatotic liver disease.内质网应激抑制剂可能替代袖状胃切除术来缓解代谢功能障碍相关脂肪性肝病。
Clin Res Hepatol Gastroenterol. 2023 Dec;47(10):102229. doi: 10.1016/j.clinre.2023.102229. Epub 2023 Oct 20.
8
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.2024年更新：巴西糖尿病学会关于糖尿病前期或2型糖尿病患者代谢功能障碍相关脂肪性肝病（MASLD）管理的立场
Diabetol Metab Syndr. 2024 Jan 19;16(1):23. doi: 10.1186/s13098-024-01259-2.
9
Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).甲状腺激素与线粒体功能障碍：代谢功能障碍相关脂肪性肝病（MASLD）的治疗意义。
Cells. 2023 Dec 9;12(24):2806. doi: 10.3390/cells12242806.
10
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy.中性内肽酶活性在代谢功能障碍相关脂肪性肝病中升高，在减肥手术或胰高血糖素样肽-1治疗后恢复正常。
iScience. 2023 Oct 12;26(11):108190. doi: 10.1016/j.isci.2023.108190. eCollection 2023 Nov 17.

引用本文的文献

1
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: UPDATE.代谢功能障碍相关脂肪性肝病：最新进展
Arq Gastroenterol. 2025 Sep 5;62:e24117. doi: 10.1590/S0004-2803.24612025-117. eCollection 2025.

本文引用的文献

1
Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2.0 procedure.经内镜 2.0 程序治疗后，非酒精性脂肪性肝病成人患者的肝脂肪变性、肥胖和胰岛素抵抗得到改善。
Endoscopy. 2023 Nov;55(11):1028-1034. doi: 10.1055/a-2117-6274. Epub 2023 Jun 26.
2
Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.肥胖症的内镜治疗：内镜袖状胃成形术对6个月和1年时体重减轻及合并症的影响
J Visc Surg. 2023 Apr;160(2S):S38-S46. doi: 10.1016/j.jviscsurg.2022.12.003. Epub 2023 Jan 30.
3
Comparison of endoscopic sleeve gastroplasty versus surgical sleeve gastrectomy: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database analysis.
内镜袖状胃成形术与外科袖状胃切除术的比较：代谢和减重手术认证和质量改进计划数据库分析。
Gastrointest Endosc. 2023 Jan;97(1):11-21.e4. doi: 10.1016/j.gie.2022.07.017. Epub 2022 Jul 21.
4
Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis.内镜减肥治疗与十二指肠空肠旁路管改善非酒精性脂肪性肝炎的非侵入性标志物。
Obes Surg. 2022 Aug;32(8):2495-2503. doi: 10.1007/s11695-022-06150-5. Epub 2022 Jun 17.
5
Prospective Multicenter Study of the Primary Obesity Surgery Endoluminal (POSE 2.0) Procedure for Treatment of Obesity.原发性肥胖症手术腔内治疗（POSE 2.0）治疗肥胖症的前瞻性多中心研究
Clin Gastroenterol Hepatol. 2023 Jan;21(1):81-89.e4. doi: 10.1016/j.cgh.2022.04.019. Epub 2022 May 6.
6
Trends in the Utilization of Intragastric Balloons: a 5-Year Analysis of the MBSAQIP Registry.胃内球囊使用趋势：MBSAQIP 注册中心的 5 年分析。
Obes Surg. 2022 May;32(5):1649-1657. doi: 10.1007/s11695-022-06005-z. Epub 2022 Mar 15.
7
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study.内镜下十二指肠黏膜重铺术治疗非酒精性脂肪性肝炎（NASH）：一项试点研究。
Endosc Int Open. 2021 Nov 12;9(11):E1792-E1800. doi: 10.1055/a-1550-7668. eCollection 2021 Nov.
8
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.水热十二指肠黏膜表面重建术治疗 2 型糖尿病患者的安全性和有效性：随机、双盲、假手术对照、多中心 REVITA-2 可行性试验。
Gut. 2022 Feb;71(2):254-264. doi: 10.1136/gutjnl-2020-323608. Epub 2021 Feb 17.
9
Once-Weekly Semaglutide in Adults with Overweight or Obesity.每周一次司美格鲁肽在超重或肥胖成人中的应用。
N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10.
10
Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty.内镜下袖状胃成形术后胰岛素抵抗及估计的肝脂肪变性和纤维化改善情况。
Gastrointest Endosc. 2021 May;93(5):1110-1118. doi: 10.1016/j.gie.2020.08.023. Epub 2020 Aug 27.